i-SENS, Inc. (KOSDAQ:099190)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,070
+10 (0.06%)
Aug 8, 2025, 3:30 PM KST
0.06%
Market Cap498.48B
Revenue (ttm)299.00B
Net Income (ttm)1.07B
Shares Out27.59M
EPS (ttm)38.23
PE Ratio466.15
Forward PE100.53
Dividend100.00 (0.55%)
Ex-Dividend DateDec 27, 2024
Volume44,259
Average Volume70,849
Open18,220
Previous Close18,060
Day's Range18,000 - 18,440
52-Week Range12,970 - 21,000
Beta0.82
RSI51.76
Earnings DateAug 14, 2025

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2000
Employees 860
Stock Exchange KOSDAQ
Ticker Symbol 099190
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.